CROSSPOINT FINANCIAL, LLC - Q2 2023 holdings

$9.83 Million is the total value of CROSSPOINT FINANCIAL, LLC's 10 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 11.1% .

 Value Shares↓ Weighting
BRKB  BERKSHIRE HATHAWAY INC DELcl b new$2,934,305
+10.4%
8,6050.0%29.85%
+4.3%
FIVG SellETF SER SOLUTIONSdefiance next$2,308,652
+1.4%
68,581
-1.2%
23.49%
-4.2%
OIH  VANECK ETF TRUSToil services etf$1,319,796
+3.8%
4,5890.0%13.43%
-2.0%
IHAK BuyISHARES TRcybersecurity$1,287,195
+4.0%
34,035
+0.0%
13.10%
-1.7%
 FIRST TR EXCHNG TRADED FD VIft cboe vest us$771,023
+4.1%
23,0500.0%7.84%
-1.7%
IAU  ISHARES GOLD TRishares new$729,331
-2.6%
20,0420.0%7.42%
-8.0%
FB BuyMETA PLATFORMS INCcl a$311,374
+49.2%
1,085
+10.2%
3.17%
+40.9%
TERN  TERNS PHARMACEUTICALS INC$105,473
-26.1%
12,0540.0%1.07%
-30.2%
ALLO NewALLOGENE THERAPEUTICS INC$59,64012,000
+100.0%
0.61%
 MICROVAST HOLDINGS INC*w exp 04/01/202$2,050
+7.4%
10,0000.0%0.02%0.0%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-08-10
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BERKSHIRE HATHAWAY INC DEL4Q3 202331.9%
ETF SER SOLUTIONS4Q3 202324.5%
VANECK ETF TRUST4Q3 202317.1%
ISHARES TR4Q3 202315.4%
FIRST TR EXCHNG TRADED FD VI4Q3 20238.1%
ISHARES GOLD TR4Q3 20238.1%
MICROVAST HOLDINGS INC4Q3 20230.0%
META PLATFORMS INC3Q3 20233.4%
TERNS PHARMACEUTICALS INC3Q2 20231.7%
ALLOGENE THERAPEUTICS INC2Q3 20230.6%

View CROSSPOINT FINANCIAL, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-04-24
13F-HR2024-02-07
13F-HR2023-11-14
13F-HR2023-08-10
13F-HR2023-05-12
13F-HR2023-02-08

View CROSSPOINT FINANCIAL, LLC's complete filings history.

Export CROSSPOINT FINANCIAL, LLC's holdings